The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant therapy (NAT) in early breast cancer (EBC): Results from a prospective observational multicenter BRIDE study.
 
Stefania Gori
No Relationships to Disclose
 
Gianluigi Ferretti
Employment - MSD (I)
Stock and Other Ownership Interests - MSD (I)
 
Piermario Salvini
No Relationships to Disclose
 
Elisabetta Cretella
No Relationships to Disclose
 
Lorenzo Gianni
Consulting or Advisory Role - AstraZeneca; AstraZeneca; SeaGen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Novartis; Novartis; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Claudia Bighin
Honoraria - Lilly O.; Novartis; Roche
Consulting or Advisory Role - Lilly O.; Novartis; Roche
 
Angela Toss
Honoraria - Lilly; Pfizer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis
Travel, Accommodations, Expenses - Lilly; Novartis
 
Claudio Zamagni
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daichi-Sankyo; EISAI; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche; Seagen
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Medivation (Inst); Morphotek (Inst); Novartis (Inst); pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Seagen (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichi-Sankyo; Gilead Sciences; Novartis; Pfizer; Roche
 
Patrizia Vici
Consulting or Advisory Role - Eisai; Lilly O.; Pfizer
Speakers' Bureau - Eisai; Lilly O.; Pfizer
 
Catia Angiolini
No Relationships to Disclose
 
Costanza De Rossi
No Relationships to Disclose
 
Antonio Russo
No Relationships to Disclose
 
Giancarlo Bisagni
No Relationships to Disclose
 
Antonio Frassoldati
Employment - Lilly
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Novartis; Seagen
Travel, Accommodations, Expenses - Novartis
 
Laura Merlini
No Relationships to Disclose
 
Anna Cariello
No Relationships to Disclose
 
Saverio Cinieri
No Relationships to Disclose
 
Matteo Valerio
No Relationships to Disclose
 
Luca Porcu
No Relationships to Disclose
 
Fabrizio Nicolis
No Relationships to Disclose